|
|
||||||||

*
University of Texas-Houston Institute of Molecular Medicine for the Prevention of Human Diseases, and
Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School, Houston, TX 77030
Carboxypeptidase N (CPN) is a plasma zinc metalloprotease comprised
of two small subunits that have enzymatic activity, and two large
subunits, which protect the enzyme from degradation. CPN cleaves the
carboxyl-terminal amino acids arginine and lysine from biologically
active peptides such as complement anaphylatoxins, kinins, and
fibrinopeptides. To delineate the murine CPN small subunit coding
region, gene structure, and chromosome location, cDNA and genomic
clones were isolated, characterized, and used in Northern and
fluorescence in situ hybridization analyses. The results from this
study demonstrate that the murine CPN small subunit gene is a single
copy gene of
29 kb that is transcribed in the liver into a 1793-bp
mRNA with an open reading frame of 1371 nucleotides encoding 457 aa.
The gene contains nine exons ranging in size from 455 bp (exon 1) to
100 bp (exon 7), and eight introns ranging in size from 6.2 kb (intron
2) to 1.4 kb (intron 4). All intron/exon junctions follow the normal
consensus rule. The mouse CPN small subunit gene localized to
chromosomal band 19D2, which is syntenic to human chromosome 10q2325.
Primer extension experiments using mouse liver mRNA indicate one major
transcriptional initiation site and three minor sites. Sequence
analysis of the 5'-flanking region indicated a TATA-less promoter and
numerous transcription factor binding sites, which may confer
liver-specific expression of the CPN small subunit
gene.
This article has been cited by other articles:
![]() |
D. A. Davis, K. E. Singer, M. De La Luz Sierra, M. Narazaki, F. Yang, H. M. Fales, R. Yarchoan, and G. Tosato Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1{alpha} in the circulation Blood, June 15, 2005; 105(12): 4561 - 4568. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |